Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer
Abstract This study explored decreased tumor suppressor microRNA (miRNA) plasma levels in pancreatic cancer (PCa) patients to clarify their potential as novel biomarkers and therapeutic targets. We used the microRNA array-based approach to select candidates by comparing plasma levels between PCa pat...
Guardado en:
Autores principales: | Taisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Wataru Okajima, Takuma Ohashi, Jun Kiuchi, Keiji Nishibeppu, Hirotaka Konishi, Atsushi Shiozaki, Ryo Morimura, Hisashi Ikoma, Toshiya Ochiai, Kazuma Okamoto, Hiroki Taniguchi, Eigo Otsuji |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9110cec5bf674e4f95c5b2b2a7305803 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rapid fluorescence imaging of human hepatocellular carcinoma using the β-galactosidase-activatable fluorescence probe SPiDER-βGal
por: Soichiro Ogawa, et al.
Publicado: (2021) -
Combined deletion and DNA methylation result in silencing of FAM107A gene in laryngeal tumors
por: Katarzyna Kiwerska, et al.
Publicado: (2017) -
MicroRNA-107 is a novel tumor suppressor targeting POU3F2 in melanoma
por: Zhao,Guizhi, et al.
Publicado: (2020) -
β-Galactosidase is a target enzyme for detecting peritoneal metastasis of gastric cancer
por: Hidemasa Kubo, et al.
Publicado: (2021) -
Acta No. 107
por: Banco Central de Chile
Publicado: (2019)